CoCliP-BJI study: cost avoidance of clinical pharmacist-led interventions in patients with bone and joint infections - 03/09/25
, Marin Lahouati a, d, Julie Leitao b, c, Vasco Dias Meireles a, Fréderic-Antoine Dauchy b, Fabien Xuereb a, dHighlights |
• | Clinical pharmacy in the management of patients with bone and joint infections (BJI) improves patients’ outcomes. |
• | Clinical pharmacy in the management of patients with BJI helps avoid preventable healthcare costs. |
• | The cost-benefit ratio associated with the intervention of pharmacists was estimated to be 2.09:1. |
Abstract |
Objectives |
Patients with bone and joint infections (BJI) are part of a complex care pathway. This study aimed to evaluate the economic impact of clinical pharmacist-led interventions in the management of BJI patients.
Patients and Methods |
We performed a retrospective study documenting all pharmacist-led interventions (PI). Their impact was assessed using the clinical economic and organizational scale (CLEO SFPC). The probability of adverse drug events (ADE) in the absence of PI was assessed by a panel of three experts. Cost avoidance was calculated for PIs with major clinical impact using a cost of €5,331 per event, multiplied by the probability of ADE occurrence.
Results |
A total of 41 PIs had a major clinical impact. Cost avoidance associated with the intervention of a pharmacist was estimated at €83,750.01 during the study.
Conclusion |
The implementation of pharmacist-led interventions in the management of patients with BJI helps avoid preventable healthcare costs.
Le texte complet de cet article est disponible en PDF.Keywords : Bone and joint infection, Antibiotics, Clinical pharmacy, Medication safety, Adverse events
Plan
Vol 55 - N° 6
Article 105104- septembre 2025 Retour au numéro
Article précédent
- Optimizing Outpatient Parenteral Antimicrobial Therapy (OPAT): A survey of community nurses’ practices in France
- S. Raux, A. Communaux, J.P. Talarmin, L. Khatchatourian
- Cutaneous infections with Corynebacterium diphtheriae in France: A cohort study
- Héloise Mazoyer, Emma d’Anglejan, Noémie Blumenthal, Alexander Younes, Anne-Laure Roux, Isabelle Bourgault Villada, Marlène Amara, Hélène Mascitti, Aurélien Dinh
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?